Acorda Therapeutics, Inc. (ACOR:NASDAQ) shot up at $0.62, representing a gain of 54.5%. On Thu, Jun 16, 2022, ACOR:NASDAQ hit a New 2-Week High of $0.62. From Thu, Jun 02, 2022, the stock recorded 60.00% Up Days and 27.27% Green Days
The stock spiked on Thu, Jun 16, 2022 at $0.79 with a volume of 53M+.
About Acorda Therapeutics, Inc. (ACOR:NASDAQ)
Acorda Therapeutics Inc is a biopharmaceutical company. It is engaged in the identification, development & commercialization of novel therapies for the treatment of neurological disorders.
Top 10 Gainers:
- Advent Technologies Holdings Inc. (ADN:NASDAQ), 243.97%
- RISE Education Cayman Ltd (REDU:NASDAQ), 138.46%
- Electric Last Mile Solutions Inc. (ELMS:NASDAQ), 100.28%
- Sidus Space Inc. (SIDU:NASDAQ), 63.03%
- Acorda Therapeutics, Inc. (ACOR:NASDAQ), 54.47%
- Heart Test Laboratories, Inc. (HSCS:NASDAQ), 42.35%
- Cango Inc. (CANG:NYSE), 40.18%
- Akanda Corp. (AKAN:NASDAQ), 32.64%
- Alpha Tau Medical Ltd. (DRTS:NASDAQ), 25.35%
- Lytus Technologies Holdings PTV. Ltd. (LYT:NASDAQ), 24.93%